Beyond the Border: How Life Sciences Leaders Are Responding to Tariff Turbulence

Tariff pressure is no longer a distant policy issue; it’s a force that’s reshaping how life sciences companies operate globally. From unexpected cost spikes to the need for vendor shifts, site transfers, and real-time regulatory updates, leaders are navigating more complexity than ever. In the midst of it all, one truth is becoming clear: tariff strategy can’t sit in a silo.

Join us for a cross-functional conversation designed to break down the silos and surface the blind spots. This panel brings together experts across Regulatory Affairs, Quality, Supply Chain, and Operations to help your team anticipate what's next and take control. Whether you're grappling with changes in China, adapting to EU expectations, or balancing cost and compliance in a reconfigured supply chain, you’ll gain insight into how leading organizations are building resilience into every layer of their global strategy.

What You’ll Learn

• How global tariff shifts are triggering regulatory, quality, and operational changes, and what your team can do now to stay ahead
• How cross-functional collaboration can reduce risk, improve inspection readiness, and ensure a fluid response to trade disruption
• Strategic tools and frameworks - including live supply chain mapping and dual sourcing models - that top companies are using to build “Tariff Resilience”

Who Should Attend

• Regulatory Affairs, Quality, and Compliance leaders navigating site transfers or labeling updates
• Supply Chain and Procurement executives facing requalification and sourcing strategy challenges
• Manufacturing and Operations leaders managing inventory risk, dual sourcing, and scenario planning
• Business unit and program leaders responsible for global market access, operational continuity, or cost containment
• Anyone developing or executing tariff response strategies across the pharma or medical device value chain

Panelists

• Claire Reade, Senior Associate, Center for Strategic and International Studies (CSIS); Senior Counsel, Arnold & Porter
• Lynn Cinelli, Vice President, Global Biologics Supply Chain, Bristol Myers Squibb
• Niall Condon, Executive Advisor, Network Partners Group
• Al Kentrup, Executive Advisor, Network Partners Group
• Lee Evans, Executive Advisor, Network Partners Group; Global Head of Regulatory Affairs, Opella
• Ritu Dhami, President, Network Partners Group - Moderator